ABI-RACE: A Phase II Open Label, Parallel group study of Abiraterone Acetate in African American and Caucasian Men with Metastic Castrate Resistant Prostate Cancer

Administered By

Awarded By

Contributors

Start/End

  • June 1, 2013 - May 31, 2021